{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:16:08Z","timestamp":1730520968448,"version":"3.28.0"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.2169\/internalmedicine.3194-23","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T22:17:16Z","timestamp":1709504236000},"page":"2929-2937","source":"Crossref","is-referenced-by-count":0,"title":["Small Insulinoma Followed-up as an Indolent Pancreatic Tumor"],"prefix":"10.2169","volume":"63","author":[{"given":"Hiroki","family":"Sato","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozaburo","family":"Fujii","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kamikokura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihiro","family":"Fujiya","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1186\/s12885-020-07581-y","volume":"20","author":"T Masui","year":"2020","unstructured":"1. Masui T, Ito T, Komoto I, Uemoto S; JNET Project Study Group. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer 20: 1104, 2020.","journal-title":"BMC Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Das S, Dasari A. Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: Are there global differences? Curr Oncol Rep 23: 43, 2021.","DOI":"10.1007\/s11912-021-01029-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58-64, 2015.","DOI":"10.1007\/s00535-014-0934-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol 6: 229-237, 2010.","DOI":"10.2217\/fon.09.165"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gaujoux S, Partelli S, Maire F, et al. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 98: 4784-4789, 2013.","DOI":"10.1210\/jc.2013-2604"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kurita Y, Hara K, Kuwahara T, et al. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis. J Gastroenterol 55: 543-552, 2020.","DOI":"10.1007\/s00535-019-01655-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sugawara T, Rodriguez Franco S, Kirsch MJ, et al. Evaluation of survival following surgical resection for small nonfunctional pancreatic neuroendocrine tumors. JAMA Netw Open 6: e234096, 2023.","DOI":"10.1001\/jamanetworkopen.2023.4096"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sallinen VJ, Le Large TYS, Tieftrunk E, et al; the Pancreas 2000 research group. Prognosis of sporadic resected small (\u22642 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study. HPB (Oxford) 20: 251-259, 2018.","DOI":"10.1016\/j.hpb.2017.08.034"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sada A, Glasgow AE, Vella A, Thompson GB, McKenzie TJ, Habermann EB. Malignant insulinoma: a rare form of neuroendocrine tumor. World J Surg 44: 2288-2294, 2020.","DOI":"10.1007\/s00268-020-05445-x"},{"key":"10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pan.2018.01.009","volume":"18","author":"AB Camara-de-Souza","year":"2018","unstructured":"10. Camara-de-Souza AB, Toyoshima MTK, Giannella ML, et al. Insulinoma: a retrospective study analyzing the differences between benign and malignant tumors. Pancreatology 18: 298-303, 2018.","journal-title":"Pancreatology","ISSN":"http:\/\/id.crossref.org\/issn\/1424-3903","issn-type":"print"},{"key":"11","unstructured":"11. National Comprehensive Cancer Network. Neuroendocrine and adrenal tumors (version 1.2023) [Internet]. [cited 2023 Jun 4]. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1448."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. Journal of Gastroenterology 56: 1033-1044, 2021.","DOI":"10.1007\/s00535-021-01827-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pavel M, Oberg K, Falconi M, et al; the ESMO Guidelines Committee. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31: 844-860, 2020.","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sadot E, Reidy-Lagunes DL, Tang LH, et al. Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study. Ann Surg Oncol 23: 1361-1370, 2016.","DOI":"10.1245\/s10434-015-4986-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Eusebi LH, Thorburn D, Toumpanakis C, et al. Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors. Endosc Int Open 7: E1393-E1399, 2019.","DOI":"10.1055\/a-0967-4684"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Brown LR. Whipple's triad: the often-overshadowed legacy of Allen Oldfather Whipple. Br J Surg 108: e76, 2021.","DOI":"10.1093\/bjs\/znaa093"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol 19: 829-837, 2013.","DOI":"10.3748\/wjg.v19.i6.829"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hong X, Qiao S, Li F, et al. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut 69: 877-887, 2020.","DOI":"10.1136\/gutjnl-2018-317233"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang H, Bender A, Wang P, et al. Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas. Nat Commun 8: 767, 2017.","DOI":"10.1038\/s41467-017-00992-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Vashi PG, Gupta D, Dahlk S. A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course. Pancreas 40: 781-784, 2011.","DOI":"10.1097\/MPA.0b013e318212c42d"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohn JH, Kim YG, Lee SH, Jung HS. Transformation of nonfunctioning pancreatic neuroendocrine carcinoma cells into insulin producing cells after treatment with sunitinib. Endocrinol Metab (Seoul) 28: 149-152, 2013.","DOI":"10.3803\/EnM.2013.28.2.149"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nahmias A, Grozinsky-Glasberg S, Salmon A, Gross DJ. Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease. Endocrinol Diabetes Metab Case Rep 2015: 150032, 2015.","DOI":"10.1530\/EDM-15-0032"},{"key":"23","unstructured":"23. Juhlin CC, Skoglund S, Juntti-Berggren L, Karlberg M, Calissendorff J. Non-functioning neuroendocrine pancreatic tumors transforming to malignant insulinomas - four cases and review of the literature. Neuro Endocrinol Lett 40: 175-183, 2019."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kessoku T, Kobayashi N, Yoneda M, et al. Case reports: transformation of end-stage neuroendocrine tumors with uncontrollable liver metastasis into a novel or additional functional phenotype. Front Oncol 10: 555963, 2020.","DOI":"10.3389\/fonc.2020.555963"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Koshy AA, Gordon IO, Van Ha TG, Kaplan EL, Philipson LH. Metastatic insulinoma following resection of nonsecreting pancreatic islet cell tumor: a case report and review of the literature. J Investig Med High Impact Case Rep 1: 2324709612473274, 2013.","DOI":"10.1177\/2324709612473274"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Arslan MS, Ozbek M, Karakose M, et al. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma. Arch Endocrinol Metab 59: 270-272, 2015.","DOI":"10.1590\/2359-3997000000049"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Keen F, Iqbal F, Owen P, Christian A, Kumar N, Kalhan A. Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma. Endocrinol Diabetes Metab Case Rep 2020: 20-0065, 2020.","DOI":"10.1530\/EDM-20-0065"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_3194-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:30:40Z","timestamp":1730518240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_3194-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3194-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"3194-23"}}